Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc KHTRF


Primary Symbol: T.GUD

Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Bullboard (TSX:GUD)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Comment by russteron Nov 17, 2022 4:26pm

RE:RE:RE:RE:RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?

Good for you CC, making it a mission keeping Mugsy in line. I get a good laugh from both of you guys? Alas you are right though GUD is probably the most boring sock on the TSX. And the USLESS ...more  
155
Discussion
Comment by MrMugsyon Nov 13, 2022 1:00pm

RE:RE:RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?

Absolutely - this is exactly how Samira/Goodman build a powerhouse in ROW. Selling in LATAM will always be evaluated and new strategies set if need be. Where to take Exelon will be discussed - rights ...more  
226
Discussion
Comment by Chianchinon Nov 12, 2022 5:05pm

RE:RE:RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?

I totally agree the plan is to keep losing fortunes on generics, latam and argentina with inflation rate "oficlaly" 85% reality 200%.  Time to turf MNT and BDO out. Meir knew better ...more  
150
Discussion
Comment by curiousjon Nov 12, 2022 11:12am

RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?

$6mn of OCF is due to settlement with GBT , equivalent to 50% of OCF for q3
136
Discussion
Comment by curiousjon Nov 12, 2022 11:05am

RE:RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?

keep in mind that Exelon is a branded generic and the focus with the new head of branded generics at Knight will be to right size the business and refocus on the right categories and brands... also ...more  
148
Discussion
Comment by gudisgoodon Nov 12, 2022 7:07am

RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?

I would agree that faith in management's ability is required in this case. I think we're always hoping for better quarters, but I truly don't think this was a bad quarter at all (not that ...more  
175
Discussion
Comment by Chianchinon Nov 11, 2022 6:21pm

RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?

The Kinight horse has only one leg left and few i..diots following 
100
Discussion
Comment by longrun86on Nov 11, 2022 5:56pm

RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?

I think we can agree that it wasn't exactly the result we had hoped for. I am still optimistic for the platform in the long term. The GBT acquisition is still being worked out and the return ...more  
150
Discussion
Post by GoldenInvestoron Nov 11, 2022 3:50pm

Stifel Healthcare conference on Tuesday

in New York. With our increased size and scale and efficiency of operations, New York will allow may more investor eyeblalls to be made aware of Knight. GI
137
Comment by gudisgoodon Nov 11, 2022 11:10am

RE:Impacted by end of agrements in LATAM- is this only Gilead ?

There were a few factors offsetting growth this quarter: No covid sales and no Gilead sales ($10.5M) Lower levels of Exelon sales due to advande buying in the last quarter ($2M) Lower ...more  
172
Discussion
Comment by MrMugsyon Nov 11, 2022 10:40am

RE:Impacted by end of agrements in LATAM- is this only Gilead ?

From what I recall - only Gilead. Also - there will always be quarters where growth stalls/pauses. What is the next leg of growth?  Likely further growth in Exelon to continue. Singular Genomics ...more  
137
Discussion
Post by Chianchinon Nov 10, 2022 7:52am

Results

No polite words exist to explain this MNGT performance. 10 Years and one billion dollars squandered. 
481
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities